phone icon (917) 310-3371 Book Risperdal Consta evaluation
Nao Medical

Long-acting risperidone

Risperdal Consta Injection Care in New York

Prescriber-led evaluation and coordination for a long-acting risperidone injection given every two weeks.

Risperdal Consta is approved for schizophrenia and for maintenance treatment of bipolar I disorder as monotherapy or with lithium or valproate. The label calls for deep deltoid or gluteal intramuscular injection every two weeks and three weeks of oral risperidone or another antipsychotic after the first injection. Nao confirms the full plan before administration.

Nao Medical patient consultation
Nao Medical clinical visit
Nao Medical clinic interior
Evaluation comes before treatment A virtual psychiatric evaluation comes first. Product, order, delivery, staff, and site are confirmed separately.

Risperdal Consta initiation and maintenance details

The delayed release makes oral coverage and accurate injection dates essential parts of the treatment record.

Approved uses

The label includes schizophrenia and maintenance treatment of bipolar I disorder as monotherapy or adjunctive therapy to lithium or valproate.

Oral tolerability

A patient who has never taken oral risperidone should establish tolerability before starting Risperdal Consta.

Initial oral coverage

Oral risperidone or another antipsychotic continues for three weeks after the first injection, then stops under the prescriber's plan.

Dose and site

The labeled usual adult starting dose is 25 mg every two weeks, with prescriber-selected adjustments and deep deltoid or gluteal administration.

What the psychiatric and administration teams verify

A complete record protects against a treatment gap during the delayed-release period.

1. Psychiatric assessment

Confirm diagnosis, treatment goals, prior response, oral tolerability, current symptoms, adverse effects, and whether another medicine remains active.

2. Initiation or continuation plan

Document the exact dose, first or last injection date, three-week oral coverage when starting, next due date, and responsible prescriber.

3. Safety and access review

Review interactions, kidney or liver considerations, pregnancy, metabolic and movement monitoring, benefits, delivery, and medication arrival.

4. Injection and follow-up

Use the correct product components and muscle site, document the dose, monitor as clinically required, and schedule psychiatric follow-up and the next injection.

What to prepare for the first evaluation

Complete records reduce avoidable delays and help the clinician separate a new decision from continuation of an established plan.

  • Current and past risperidone doses, response, oral tolerability, and side effects.
  • Last injection date, prescribed dose, injection site, next due date, and any oral-coverage plan.
  • Current medicines, allergies, recent weight, blood pressure, glucose or lipid results, and movement-symptom history.
  • Outside order, responsible prescriber contact, insurance, and pharmacy or delivery details.

Safety, monitoring, and treatment boundaries

The clinical plan is individualized. These points highlight questions that need explicit review rather than replacing the current label, a full evaluation, or emergency care.

Metabolic monitoring

Risperidone can affect weight, blood glucose, and lipids; the prescriber sets baseline and follow-up monitoring.

Movement and prolactin effects

Review stiffness, tremor, restlessness, involuntary movement, menstrual or sexual changes, breast symptoms, and other possible prolactin effects.

Blood pressure and sedation

Orthostatic blood-pressure changes, sleepiness, and falls can matter, especially with other medicines or medical conditions.

Late injections

There is no single restart instruction for every gap. The prescriber reviews the prior treatment stage and may need oral antipsychotic coverage.

When to get urgent or emergency help

Seek urgent care for high fever with severe stiffness or confusion, fainting, a seizure, serious allergic symptoms, uncontrolled movements, or immediate risk of harm.

Virtual evaluation first, administration site confirmed later

Start with virtual psychiatry. The team reviews the medicine, order, dose history, delivery, trained staff, and site before scheduling an in-person injection. Do not arrange a shipment or travel to a clinic until the team confirms the plan.

Choose condition-focused care for diagnosis and long-term treatment planning. Choose a medicine-specific service for initiation, access, monitoring, delivery, or administration questions.

Uzedy injection

Review the separate subcutaneous risperidone schedule and initiation rules; the products are not interchangeable.

Clinical and regulatory sources

These authoritative sources were checked on August 1, 2026. Drug labels and guidance can change, so the treating clinician uses current information for each decision.

Common questions about Risperdal Consta

The current label describes deep intramuscular administration every two weeks by a healthcare professional.
The label calls for oral risperidone or another antipsychotic with the first injection and for three weeks afterward to provide therapeutic coverage.
It is given as a deep intramuscular injection in the deltoid or gluteal muscle using the product's corresponding needle and site instructions.
It is approved for maintenance treatment of bipolar I disorder as monotherapy or as adjunctive therapy to lithium or valproate. An evaluation determines whether it fits an individual's plan.
No automatic conversion is assumed. The prescriber must account for the prior product's release pattern, last dose, current symptoms, and Risperdal Consta initiation requirements.
Contact the prescriber before another injection. The plan depends on treatment history and the length of the gap, and oral antipsychotic coverage may be needed.
Nao can review a valid order and records. Administration depends on order acceptance, a responsible prescriber, medication delivery, trained staff, and a confirmed clinic.
Monitoring may include symptoms, movement effects, weight, glucose, lipids, blood pressure, sedation, prolactin-related effects, interactions, and injection-site concerns.
Book Risperdal Consta evaluation Call with questions

Updated August 1, 2026. This information does not replace an individual medical evaluation. A licensed clinician determines diagnosis, medication eligibility, prescribing, testing, dosing, administration, and follow-up.

Health information notice

General information only. This page is not medical advice and does not replace diagnosis, treatment, or guidance from a licensed clinician.

Content was updated August 1, 2026 from the sources cited on this page. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.